Fondation de l'Avenir

What Fondation de l'Avenir does

Fondation de l'Avenir is a French non-profit foundation recognized as being in the public interest (reconnue d'utilité publique), founded in 1987 and headquartered at 255 rue de Vaugirard in Paris (15th arrondissement). It operates as a bridge between fundamental research and clinical application, funding applied medical research across all French medical specialties including surgery, cardiology, oncology, neurosciences, digital health, nursing sciences, and cellular therapy. Its core offering centers on the annual Appel à Projets Recherche Médicale (APRM), which selects approximately 35-40 projects from around 150 applications for seed funding averaging €37,000 per project, alongside multi-year research programs (Programme Ptolémée on brain mapping, Lights For hEart on cardiac treatment), research prizes (Trophées de l'Avenir since 2004, Prix des Chirurgiens de l'Avenir since 2008, Prix CASDEN du Jeune Chercheur since 2009, Prix Avenir Recherche Innovation since 2017), the Bourse Avenir Recherche en Soins (BARS) for paramedical professionals, and the biennial Baromètre Recherche Médicale (BRM) public perception survey.

The foundation's revenue model is entirely private with no public subsidies: approximately 62% from public generosity (donations, bequests, life insurance), 23% from partner contributions (mutual insurance companies, sheltered foundations, support funds), and 15% from other products (solidarity savings, rental income, financial revenues). In 2025 it deployed €5.7 million toward social missions across its own operations and six sheltered foundations, with €6 million in annual funds mobilized. The foundation is staffed by 17 permanent employees organized across two thematic poles (Pôle Instances, Ressources et Performances and Pôle Recherche Innovation et Accompagnement), supported by 159 volunteers including governance members and scientific experts contributing 591 hours of governance work, and engages 40,000+ individual donors and 40 major partner institutions led by Mutualité Française, Matmut, MGEN, Groupe VYV, CASDEN Banque Populaire, and the Académie Nationale de Chirurgie.

Beyond direct research funding, the foundation operates a sheltered foundation model since 1992, enabling partner organizations to create their own foundations under its public utility umbrella, and has launched three support funds (Fonds Avenir Masfip for oncogenetics, Fonds Avenir Santé Numérique for digital health, Fonds Avenir Matmut for psychiatry). Communications are delivered through the quarterly Fonder l'Avenir donor magazine, weekly L'Echo newsletter, LinkedIn and YouTube channels, and events including the biennial Trophées de l'Avenir and Journées de l'Avenir (with the Ligue Nationale de Basket). The foundation operates under a 2022/2030 strategic orientations plan approved by the supervisory board in 2021, with governance led by President of the Directoire Marion Lelouvier and President of the Supervisory Board Matthias Savignac.

Name

Fondation de l'Avenir

Legal name

Fondation de l'Avenir

Website

https://fondationdelavenir.org

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Short description

Fondation de l'Avenir is a French non-profit public utility foundation that funds applied medical research across all specialties via annual seed grants. Founded in 1987, it supports 35-40 research projects annually from ~150 applications, funded entirely by private donations and partnerships.

Ownership category

akta.pro rank

Product category

Medical Research Foundation

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Other Grantmaking and Giving Services (813219)

SIC

Services-Social Services (8300)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Research & Science Grantmaking Foundations (BPAGAKAI), International Grantmaking & Development Foundations (BPAGAKAH)

Keywords

• Medical research grants
• Applied medical research
• Healthcare research funding
• Scientific research support
• Nonprofit research foundation

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Others, Personnel, Operations, Marketing or Sales

Revenue model

1. Public Generosity (Dons et Legs): Approximately 62% of resources come from public donations, bequests, and life insurance contributions. Individual donors contribute through one-time donations, monthly direct debits, and legacy planning.
2. Partner Contributions (Fonds Partenaires): Approximately 23% of funding comes from institutional partners including mutual insurance companies, sheltered foundations, and support funds. These include both monetary contributions and in-kind patronage such as skills and services.
3. Other Products (Autres Produits): Approximately 15% from other sources including solidarity savings products, rental income, and financial revenues

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Fondation de l'Avenir is a French non-profit foundation recognized as a public utility since 1988 that accelerates applied medical research in France. It funds research through annual calls for projects (APRM), research prizes, BARS scholarships, multi-year research programs, and sheltered sub-foundations. The foundation channels donor contributions to researchers and clinical teams across all medical disciplines.

Product overview

Fondation de l'Avenir is a charitable foundation recognized for public utility since 1988, dedicated to accelerating applied medical research for immediate patient benefit. The foundation operates as a unified platform offering multiple complementary mechanisms to support researchers at all career stages: an annual Call for Research Projects (APRM) selecting approximately 35 projects yearly, research prizes (Prix) including the biennial Trophées de l'Avenir and Prix des Chirurgiens de l'Avenir since 2008, the BARS grant program for paramedical professionals since 2013, multi-year research programs (Programmes), the biennial Baromètre Recherche Médicale (BRM) public perception survey, and communication vehicles including the quarterly Fonder l'Avenir donor magazine and weekly L'Echo newsletter. The foundation channels private funding only—no public subsidies—to support innovation across surgery, cardiology, oncology, neuroscience, digital health, and other medical fields, serving as a bridge between fundamental research and clinical application.

Differentiator

Problem solved

Functional benefit

Brands

• Baromètre Recherche Médicale (BRM): Study published every two years representing the perception of Applied Medical Research by French citizens and healthcare professionals
• Trophées de l'Avenir
• Prix des Chirurgiens de l'Avenir
• Prix Avenir Recherche Innovation (PARI)
• Prix CASDEN du Jeune Chercheur
• Journées de l'Avenir (JDA)
• Bourse Avenir Recherche en Soins (BARS)
• Appel à Projets Recherche Médicale (APRM)

Products and services

• APRM - Annual Call for Research Projects (Appel à Projets de Recherche Médicale) An annual open call for medical research projects that allows researchers and clinical teams across France to apply for seed funding for innovative applied research. Targeted at hospital-based clinicians, university researchers, and translational medicine teams.

Quantifiable outcome

• 5.7 million euros dedicated to social missions in 2025
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

17 partnerships are on record, tiered core and minor.

• Mutualité Française (FNMF)coreStrategic or Co-development PartnerHistorical partner supporting foundation activities. Co-creator of Prix Avenir Recherche Innovation (PARI) since 2017. La Mutualité Française supports the foundation through fonds Avenir Partage ISR and participates in governance.
• MatmutcoreStrategic or Co-development PartnerMajor historical partner through both direct sponsorship and sheltered foundations (Fondation Matmut Paul Bennetot, Fonds Avenir Matmut). Supports Prix de l'innovation médicale at Trophées de l'Avenir.
• CASDEN Banque PopulairecoreStrategic or Co-development PartnerSupports Prix CASDEN du Jeune Chercheur since 2009, awarded to young researcher under 40 selected from APRM projects.
• Fondation Matmut Paul Bennetot (sheltered)coreStrategic or Co-development PartnerSheltered foundation supporting innovation and research in traumatology and post-traumatology, as well as dependency related to progressive and irreversible disease.
• Fondation Sandrine Castellotti (sheltered)coreStrategic or Co-development PartnerSheltered foundation dedicated to raising awareness of treatments for eating disorders (TCA) to accelerate screening and therapeutic care for patients.
• Fondation Écouter Voir (sheltered)coreStrategic or Co-development PartnerSheltered foundation supporting research programs on hearing and vision disorders.
• Fondation MUTAC (sheltered)coreStrategic or Co-development PartnerSheltered foundation supporting the fight against isolation of elderly people by promoting intergenerational connections. Awards 20,000€ annually to two structures.
• Fondation Mutuelle des Motards (sheltered)coreStrategic or Co-development PartnerSheltered foundation supporting research and innovation for the benefit of two and three-wheeled motor vehicle users.
• Fondation Solimut Mutuelle de France (sheltered)coreStrategic or Co-development PartnerSheltered foundation acting for reduction of inequalities, access to healthcare for all, and continuity of care.
• Fonds Avenir MasfipcoreStrategic or Co-development PartnerSupport fund created by MASFIP and Fondation de l'Avenir for medical research and new care practices in oncogenetics.
• Fonds Avenir Santé NumériquecoreStrategic or Co-development PartnerNon-endowment fund under foundation's umbrella dedicated to promoting digital health innovation.
• Groupe VYVcoreStrategic or Co-development PartnerFirst mutual health and social protection group, supports Prix de la Recherche en Sciences Infirmières at Trophées de l'Avenir.
• Ligue Nationale de BasketminorStrategic or Co-development PartnerPartnership for Journées de l'Avenir, annual basketball matches to raise awareness of cardiac pathologies and raise funds for cardiac research.
• Académie Nationale de ChirurgiecoreStrategic or Co-development PartnerInstitutional partner with two seats on the supervisory council, representing public academic institutions.
• Association Française de Cautionnement Mutuel (AFCM)coreStrategic or Co-development PartnerSupports financing of projects from public establishments and hospitals. Co-funds Médaille Jean Bayle Lespiteau at Trophées de l'Avenir.
• La Chaîne de l'EspoirminorStrategic or Co-development PartnerPartnership established March 2022 to support training of Ukrainian civilian medics in war medicine through Professor Raphael Pitti, with training centers in Metz and Lviv.
• Fondation Croix-Rouge françaiseminorStrategic or Co-development PartnerTwo research partnerships supporting projects on care access for elderly Ukrainian refugees in France and their access to healthcare.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Fondation pour la Recherche Médicale (FRM): FRM is France's largest private funder of medical research, supporting all medical disciplines through grants and fellowships. Like FDA, it channels private donations to a portfolio of research projects and operates annual calls for proposals, making it a direct comparator in the French medical-research grantmaking space.
• Ligue contre le cancer: Ligue contre le cancer is one of France's largest health-focused non-profits, funding cancer research through donations and partnerships. Its research-grant programme and donor-funded model align closely with FDA's value proposition, although it is monothematic (cancer) versus FDA's generalist approach.
• Fondation Maladies Rares: Fondation Maladies Rares is a French non-profit foundation that funds research on rare diseases through grants and calls for projects. It mirrors FDA's grantmaking, scientific-council evaluation, and partnership-based funding model, albeit focused on a specific therapeutic area.
• Fondation de France: Fondation de France is a multi-purpose grantmaking foundation that, similar to FDA, shelters partner foundations under its umbrella and distributes funds across health, research, and social causes. Its mixed-portfolio model and sheltering capability make it a structural twin to FDA, though at significantly larger scale.
• Fondation ARC pour la recherche sur le cancer: ARC is a France-based cancer-focused grantmaking foundation that funds research projects, awards prizes, and supports researchers across career stages. It is directly comparable to FDA's disease-specific sheltered foundations (e.g., Matmut for traumatology) and operates in the same medical-research grantmaking category.

Broad incumbents

• Institut Pasteur: Institut Pasteur is a globally recognised French biomedical research institution that conducts research and awards grants/external funding. While much larger and an active research performer rather than a pure grantmaker, it overlaps with FDA in the French medical-research funding ecosystem and is a frequent indirect collaborator with FDA-funded teams.
• Agence Nationale de la Recherche (ANR): ANR is France's primary public research funding agency, distributing competitive grants across all scientific disciplines including health. Its project-based funding model is structurally similar to FDA's APRM, and FDA functions as a complementary private seed-funder that often precedes ANR-scale awards.
• INSERM: INSERM is France's national institute for health and medical research, the largest public funder and performer of biomedical research in the country. It represents the dominant counterpart in the French medical-research ecosystem, and many FDA-funded researchers are affiliated with INSERM laboratories.

Emerging players

• Fondation pour la Recherche Stratégique: Fondation pour la Recherche Stratégique is a French non-profit foundation supporting research, though primarily in strategic/defence studies rather than health. It demonstrates the broader French foundation-grantmaking ecosystem in which FDA operates, with comparable governance and donor models.

Regional players

• Fondation Hôpitaux de Paris-Hôpitaux de France: Fondation Hôpitaux de Paris-Hôpitaux de France is a French hospital-focused foundation that funds care improvement and research projects. It shares the French hospital-research ecosystem with FDA and represents a comparable donor-funded grantmaking model, though oriented toward hospital infrastructure rather than basic research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCB3iQ5SUQ1ayGGXfVrzK71A
• LinkedInlinkedin.com/company/fondation-de-l'avenir

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fondation de l'Avenir